General Information
BounceWatch is an independent company data service, not affiliated with Contraline. To contact Contraline, visit contraline.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Contraline
Taxonomy: medical device, urology, contraception, women's health, reproductive health, men's health
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $7.20M | 8 | 10 Nov 2022 | |
| Series A | $10.70M | 10 | 20 Oct 2021 | |
| Grant | $600.00K | 1 |
Virginia Catalyst
|
26 Oct 2020 |
| Venture Round | Undisclosed | 3 | 27 Apr 2020 | |
| Grant | $200.00K | - |
|
24 Jan 2019 |
| Seed Round | $3.00M | 10 | 18 Sep 2018 | |
| Seed Round | $2.25M | 8 | 31 Mar 2017 | |
| Pre Seed Round | $680.00K | 3 | 01 Jun 2016 |
Contraline Alternatives & Competitors
View All AlternativesFrom infertility to fatherhood
A preclinical-stage women’s health biotech focused uniquely on ovarian biology.
The Stork Ib2C, A Rinovum Women’s Health Company is a women’s health company dedicated to bringing p...
FAQ About Contraline
Source: BounceWatch company record for Contraline, https://bouncewatch.com/company/contraline, updated 30 December 2024. When citing, please name BounceWatch and link this page.